This epigenetic control results in the modulation of genes involved in HCC progression, such as Ras association domain family member 1 (RASSF1), GATA binding protein 4 (GATA4), and cyclin dependent kinase like 2 (CDKL2) [242,250]. Here, CDKL2 is linked to hepatocellular carcinoma.